Transcatheter Embolization And Occlusion Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Coil (Pushable Coils, Detachable Coils), Non-Coil (Flow Diverting Devices, Embolization Particles, Liquid Embolics, Other Embolization and Occlusion Devices, Accessories)), By Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, Others),

Market Overview

Global Transcatheter Embolization And Occlusion Devices Market was valued at USD 2.52 billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.80% through 2029. In the realm of medical devices, these products are instrumental in addressing cancers affecting various organs such as the kidneys, lungs, and liver. A significant change in the treatment approach, transitioning from traditional clipping to the modern coiling technique, has led to an increased need for transcatheter embolization devices. These devices play a crucial role in treating aneurysms, eliminating abnormal connections between arteries and veins, halting blood flow to tumors, and managing or preventing abnormal bleeding.

Key Market Drivers

Increasing Prevalence of Chronic Diseases

The prevalence of chronic diseases, such as kidney, lung, and liver malignancies, is on the rise globally. This alarming trend has spurred a demand for advanced, minimally invasive medical interventions, and it's in this context that transcatheter embolization and occlusion devices are playing a pivotal role.

Chronic diseases, often characterized by long-term, debilitating health conditions, have become a worldwide health epidemic. They encompass a broad spectrum of ailments, from various cancers to vascular anomalies like aneurysms. The growing burden of these diseases on healthcare systems and patients has amplified the need for innovative treatment options.

Traditionally, many chronic diseases required open surgeries, which were often associated with longer recovery times, higher costs, and increased risks. In contrast, transcatheter embolization and occlusion devices offer minimally invasive alternatives that promise quicker recovery, shorter hospital stays, and reduced post-operative complications. Patients and healthcare providers are increasingly opting for these less invasive procedures, driving the market's growth.

Transcatheter embolization devices are highly effective in treating cancers, particularly those located in the kidneys, lungs, and liver. These devices work by obstructing the blood supply to tumors, starving them of vital nutrients, and causing their regression. The increasing prevalence of cancer cases has driven demand for these devices, as they provide a less invasive means of tumor management.

Beyond cancer, transcatheter embolization and occlusion devices offer solutions for a wide array of vascular conditions, including aneurysms and the management of abnormal connections between arteries and veins. The ability to effectively address a spectrum of disorders within one medical field adds to the appeal of these devices, further spurring market growth.

Continuous innovation in the field of transcatheter embolization and occlusion devices has led to enhanced precision, efficiency, and safety. Improved materials, advanced imaging techniques, and navigational systems have broadened the range of treatable conditions and made the procedures even more appealing to both patients and healthcare providers.

Patient-centric care is becoming increasingly important in the healthcare sector. Patients are more empowered and informed, and they often seek treatments that align with their preferences and well-being. Transcatheter embolization and occlusion procedures align with this trend, offering patients a minimally invasive, less disruptive option for treating chronic diseases.

In an era of rising healthcare costs, the cost-effectiveness of transcatheter embolization and occlusion procedures is a significant driver of market growth. Shorter hospital stays, fewer post-operative complications, and overall lower healthcare expenditures make these procedures an attractive option for both healthcare systems and patients.

Shift towards Minimally Invasive Procedures

The realm of medical procedures is undergoing a profound transformation, marked by a noticeable shift towards minimally invasive techniques. This shift has not only changed the way patients experience medical treatments but has also played a pivotal role in the remarkable growth of the global transcatheter embolization and occlusion devices market.

Traditionally, many medical treatments required invasive surgeries, which often came with extended recovery times, higher healthcare costs, and increased risks for patients. However, the emergence of minimally invasive procedures has revolutionized the healthcare landscape. These procedures, including those employing transcatheter embolization and occlusion devices, have led to shorter recovery periods, reduced hospital stays, and fewer post-operative complications.

Patients are increasingly prioritizing their well-being and quality of life when making healthcare decisions. Minimally invasive procedures align with these values as they cause less disruption to a patient's life. Patients can often return to their daily routines sooner after minimally invasive treatments, which can have a significant positive impact on their overall experience and satisfaction.

The shift towards minimally invasive procedures has given rise to heightened patient demand. Patients are now more informed about their healthcare options and are actively seeking treatments that are less invasive and more comfortable. As patients advocate for procedures that offer quicker recovery times and improved comfort, the demand for devices such as transcatheter embolization and occlusion tools is on the rise.

Minimally invasive procedures are becoming increasingly popular among healthcare providers due to their numerous benefits. These procedures are often associated with shorter surgical times, reduced healthcare costs, and decreased post-operative complications. Healthcare providers are recognizing that embracing minimally invasive techniques, including transcatheter embolization and occlusion, can lead to improved patient outcomes and operational efficiencies.

Transcatheter embolization and occlusion devices are no longer limited to a niche medical field. They now address a diverse range of medical conditions, from cancer treatment to the management of vascular anomalies. The growing number of applications has broadened their appeal and contributed to market expansion.

Growing Awareness Among Healthcare Providers

The global healthcare landscape is continually evolving, driven by advancements in medical technology and the knowledge base of healthcare providers. One significant factor propelling the growth of the global transcatheter embolization and occlusion devices market is the increasing awareness among healthcare professionals.

Healthcare providers, including physicians and surgeons, are at the forefront of patient care. As they become more acquainted with transcatheter embolization and occlusion devices, they gain access to new and effective treatment options for a wide range of medical conditions. This awareness helps them better address patient needs and offer advanced, minimally invasive treatments.

Transcatheter embolization and occlusion devices have transcended their traditional applications and can now be used to treat a myriad of medical conditions. From cancer management to vascular anomalies and aneurysms, these devices provide versatile solutions that healthcare providers can offer to their patients. As healthcare professionals learn about these diverse applications, they are more likely to incorporate them into their practice.

Healthcare providers are driven by the goal of achieving the best possible outcomes for their patients. Transcatheter embolization and occlusion procedures have demonstrated their efficacy in improving patient outcomes, often resulting in quicker recovery times, reduced hospital stays, and fewer post-operative complications. As healthcare providers become more aware of these benefits, they are inclined to recommend and perform these procedures, thus driving market growth.

The medical community places a significant emphasis on continuous learning and professional development. As awareness of transcatheter embolization and occlusion devices grows, so does the interest in training and education related to these technologies. Physicians and medical professionals seek to enhance their knowledge and expertise in this field, which further promotes the adoption and application of these devices.

The shift towards patient-centric care places greater importance on individual patient preferences, comfort, and overall experience. Minimally invasive procedures, such as those involving transcatheter embolization and occlusion devices, align with this trend. Healthcare providers who prioritize patient well-being and satisfaction increasingly opt for these procedures, contributing to the market's growth.

Expanding Geriatric Population

The world is undergoing a demographic transformation with a rapidly increasing elderly population. This demographic shift is bringing profound changes to various sectors, including healthcare. One area where the impact is particularly notable is in the demand for advanced medical procedures and devices.

The global population is aging at an unprecedented rate, with the number of elderly individuals (aged 65 and over) expanding at a remarkable pace. This phenomenon is often referred to as the "silver tsunami" and is reshaping healthcare systems and markets worldwide. As the geriatric population grows, so too does the prevalence of age-related medical conditions, many of which can be effectively managed with transcatheter embolization and occlusion devices.

Aging is often associated with an increased risk of various health conditions, including chronic diseases and vascular disorders. The geriatric population is more prone to conditions such as kidney, lung, and liver malignancies, as well as aneurysms and vascular anomalies. Transcatheter embolization and occlusion devices offer minimally invasive treatment options that are well-suited for elderly patients, contributing to their popularity.

The healthcare industry is continually advancing, offering more sophisticated and less invasive treatment options for elderly patients. Transcatheter embolization and occlusion devices are at the forefront of these innovations, providing minimally invasive solutions that cater to the unique needs and health challenges of older individuals.

Elderly individuals often prioritize maintaining a good quality of life, even in the presence of age-related health conditions. Transcatheter embolization and occlusion procedures align with this goal by offering quicker recovery times, shorter hospital stays, and fewer post-operative complications. For the geriatric population, these advantages are particularly appealing and can significantly enhance their quality of life.

Geriatric care requires specialized attention, and healthcare providers are increasingly tailoring their services to meet the unique needs of older patients. Transcatheter embolization and occlusion devices have found their place in geriatric care as they allow for effective treatment with less strain on elderly patients, ensuring that their healthcare experience is as comfortable and efficient as possible.

In an era of increasing healthcare costs, healthcare systems are seeking efficient and cost-effective solutions for their aging populations. Transcatheter embolization and occlusion procedures offer shorter hospital stays and fewer post-operative complications, translating to cost savings for healthcare providers and systems. As a result, these procedures are becoming increasingly popular among geriatric care providers.

Key Market Challenges

Competition and Market Saturation

As the market for transcatheter embolization and occlusion devices continues to grow, competition is intensifying. Manufacturers must strive to differentiate their products and offer unique advantages to remain competitive. Market saturation is another concern, as new entrants face challenges breaking into a crowded marketplace.

Variability in Patient Populations

The effectiveness of transcatheter embolization and occlusion procedures can vary depending on patient demographics, including age, health status, and the nature of the medical condition being treated. As the patient population becomes more diverse and complex, healthcare providers must adapt their approaches and customize treatments to address these variations.

Ethical and Social Concerns

Minimally invasive procedures, while often more desirable for patients, raise ethical and social concerns. Some individuals and cultures may have reservations about such procedures, which can limit their adoption. Addressing these concerns requires effective communication and education about the benefits and safety of these treatments.

Key Market Trends

Hybrid Procedures

Hybrid procedures that combine transcatheter embolization and occlusion with other minimally invasive techniques are emerging as a promising trend. These combinations allow for more comprehensive treatment of complex medical conditions and are expected to become more common in the coming years.

Telemedicine and Remote Consultations

The COVID-19 pandemic has accelerated the adoption of telemedicine and remote consultations. This trend is likely to continue, making it easier for patients to connect with healthcare providers for pre- and post-procedural consultations. Telemedicine will play a significant role in patient follow-up and monitoring, enhancing the overall patient experience.

Value-Based Healthcare

Value-based healthcare is a growing trend aimed at providing better care at a lower cost. Transcatheter embolization and occlusion procedures, which often lead to shorter hospital stays and reduced complications, align with this approach. As healthcare systems focus more on value, the adoption of these procedures may increase.

Segmental Insights

Product Insights

Based on Product, the non-coil category emerged as the primary source of revenue in 2023 and is poised for the most rapid growth throughout the projected period. This growth is attributed to the increasing favorability of minimally invasive surgical procedures, which has generated heightened demand for these devices. Non-coils are the preferred choice due to their reduced likelihood of migration, offering a significant advantage over coil-type alternatives. The non-coils exhibit lower risks of hemolysis, as their materials do not disrupt the bloodstream's flow. Non-coils are exclusively employed in managing large defects, as coils are unsuitable for such scenarios.

Regarding product categorization, the transcatheter embolization and occlusion devices market is divided into two segmentscoils and non-coils. The non-coil segment encompasses various subcategories, including coiling assist devices, flow-diverting devices, embolization particles, liquid embolic agents, other embolization and occlusion devices, as well as associated accessories. These devices effectively address issues such as inaccurate deployment, catheter entrapment, and balloon deflation commonly associated with coiling procedures.

Application Insights

Based on application,

On the other hand, the oncology sector is projected to experience the highest CAGR up to 2030, primarily due to the effective application of embolization techniques in addressing liver and kidney cancer cases. Embolization has emerged as a pivotal treatment modality for various cancer types, including liver, kidney, breast, pancreatic, among others. Among these, hepatocellular carcinoma, a form of liver cancer, is the most prevalent condition treated using embolization procedures. As per information from the National Center for Biotechnology Information, hepatocellular carcinoma ranks as the third leading cause of cancer-related fatalities on a global scale.

Download Free Sample Report

Regional Insights

Based on region, North America took the lead in the market, securing a significant revenue share in 2023. This dominance is attributed to several key factors, including the region's advanced healthcare infrastructure, a well-defined regulatory framework, and a pool of experienced healthcare professionals. The presence of a well-established pharmaceutical industry plays a pivotal role in driving the demand for transcatheter embolization and occlusion (TEO) devices. The Centers for Disease Control and Prevention (CDC) reports that these devices find application in cases of atrial fibrillation and varicose veins. Atrial fibrillation alone affects approximately 454,000 individuals annually, and varicose veins are prevalent in 23% of U.S. adults.

On the other hand, the Asia Pacific region is poised to experience the most rapid CAGR during the forecast period. This growth is fueled by the booming medical tourism industry in emerging economies such as India, China, and Malaysia, which attracts cancer patients from across the globe. The region boasts the largest population pool and a substantial geriatric population. According to a World Health Organization (WHO) report, the Asia Pacific region is home to 414 million people aged above 60. It is anticipated that by 2050, 40% of the populations in Hong Kong and Japan will be over the age of 65, and this demographic is particularly susceptible to cardiovascular diseases (CVDs). Transcatheter embolization offers a minimally invasive treatment option for these conditions.

Recent Developments

• In April 2022, Boston Scientific Corporation unveiled a milestone achievement with the acquisition of FDA 510(k) clearance for its groundbreaking 'Embold' Fibered Detachable Coil. Designed to revolutionize vascular interventions, this innovative medical device targets the obstruction or reduction of blood flow rates within the peripheral vasculature. Engineered with advanced fiber technology, the 'Embold' Coil offers enhanced precision and efficacy in addressing vascular conditions. This regulatory clearance underscores Boston Scientific's commitment to advancing patient care through innovative medical solutions, providing healthcare professionals with a powerful tool to improve outcomes for patients with peripheral vascular disorders.
• InJuly 2021, Terumo Corporation unveiled its groundbreaking AZUR Vascular Plug, aproduct designed to work seamlessly with microcatheters for the purpose ofoccluding arteries with diameters of up to 8mm. As an integral component of thecompany's robust embolization product portfolio, the AZUR Vascular Plug isstrategically developed for the purpose of reducing or impeding blood flowwithin the arterial pathways of the peripheral vasculature.

Key Market Players

• Boston Scientific Corp
• Terumo Corp
• Medtronic PLC
• DePuy Synthes Inc
• Stryker Corp
• Cordis Corp
• Abbott Laboratories Inc
• Pfizer Inc
• Sirtex Medical Inc
• Nordion Inc

Report Scope

In this report, the Global Transcatheter Embolization And Occlusion Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below

• Transcatheter Embolization And Occlusion Devices Market, By Product

o

§

§

o

§

§

§

§

§

• Transcatheter Embolization And Occlusion Devices Market, By Application

o

o

o

o

o

• Transcatheter Embolization And Occlusion Devices Market, By Region

o

§

§

§

o

§

§

§

§

§

o

§

§

§

§

§

o

o

§

§

§

§

Competitive Landscape

Company Profiles

found at Customizations

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Transcatheter Embolization And Occlusion Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at